# FDA Inspection 707872 - Boehringer Ingelheim Roxane, Inc. - January 07, 2011

Source: https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-roxane-inc/412239f1-61f8-4a88-8a4f-22c0b24a2dd2
Source feed: FDA_Inspections

> FDA Inspection 707872 for Boehringer Ingelheim Roxane, Inc. on January 07, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 707872
- Company Name: Boehringer Ingelheim Roxane, Inc.
- Inspection Date: 2011-01-07
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 548151 - 2008-11-10](https://www.keypedia.com/records/fda_inspections/boehringer-ingelheim-roxane-inc/133e287b-a37a-43df-bf30-8685d9ea232e)

Company: https://www.keypedia.com/companies/boehringer-ingelheim-roxane-inc/ff6a43b9-fcc8-44c1-aee1-b927b9515098

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c